Written Question·Department of Health and Social Care·UIN 30123
Xanomeline/Trospium Chloride
Tabled: 10 February 2025
Answered: 14 February 2025
Question
Rachael Maskell
Labour (Co-op) — York Central
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the effectiveness of Cobenfy; and whether he is taking steps to licence this medication in the UK.
Answer
Karin SmythThe Medicines and Healthcare products Regulatory Agency has not received an application for the Market Authorisation of Cobenfy by the Bristol-Myers Squibb Company.